Precision Molecular Pathology of Hodgkin Lymphoma

Inbunden, Engelska, 2017

Del i serien Molecular Pathology Library

1 094 kr

Beställningsvara. Skickas inom 10-15 vardagar. Fri frakt över 249 kr.

Beskrivning

This text provides a comprehensive and up-to-date overview of Hodgkin lymphoma. The volume reviews every facet of the cancer in great detail, including pathology, pathobiology, molecular genetics, microenvironment, epidemiology, treatment, and new therapeutic advances. The specific role of the lymphoma microenvironment is addressed, and the relationship of Hodgkin lymphoma to related non-Hodgkin lymphomas is covered as well.Written by experts in the field, Precision Molecular Pathology of Hodgkin Lymphoma is a valuable resource for oncologists, surgeons, pathologists, clinical trainees, and investigators engaged in the diagnosis, treatment, and research studies of this lymphoid neoplasm.

Produktinformation

Utgivningsdatum:2017-12-27
Mått:155 x 235 x 19 mm
Vikt:586 g
Format:Inbunden
Språk:Engelska
Serie:Molecular Pathology Library
Antal sidor:236
Upplaga:17001
Förlag:Springer International Publishing AG
ISBN:9783319680934

Utforska kategorier

Patologi inom Medicin
Onkologi inom Medicin

Mer om författaren

S. David Hudnall, MDProfessor of Pathology and Laboratory MedicineDirector, Hematopathology ProgramAssociate Medical Director, Precipio Diagnostics, LLCYale University School of Medicine310 Cedar StreetNew Haven, CT 06520USADr. Ralf KüppersUniversity of Duisburg-EssenDepartment of Molecular GeneticsInstitute of Cell BiologyHufelandstr. 5545122 EssenGermany

Innehållsförteckning

Introduction.- Clinical features.- Histopathology of Hodgkin lymphoma and closely related lymphomas.- Pathogenesis and molecular genetics of classical Hodgkin lymphoma.- The microenvironment in classical Hodgkin lymphoma.- Role of EBV in classical Hodgkin lymphoma.- Pathobiology of nodular lymphocyte predominant Hodgkin lymphoma.- Composite lymphomas and the relationship of Hodgkin lymphoma to Non-Hodgkin lymphomas.- Epidemiology and genetic risk factors.- Treatment and Prognosis.- Development of targeted therapies.